← All trials
NCT01281202
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2011
- Primary completion
- Oct 1, 2012
- Completion date
- Dec 1, 2012
- First posted
- —
- Last posted
- —
- Enrollment
- 207
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Catalyst Pharmaceuticals, Inc.Lead sponsor
- Medical University of South CarolinaOverall official - principal investigator
- Department of Veteran AffairsStudy chair
- National Institute on Drug Abuse (NIDA)Collaborator
- Department of Veteran AffairsCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.